Foreign-Trade Zone 170-Clark County, IN; Application for Subzone; Schwarz Pharma Manufacturing Ltd. (Pharmaceuticals Manufacturing), Seymour, IN, 45612-45613 [E9-21319]
Download as PDF
45612
Federal Register / Vol. 74, No. 170 / Thursday, September 3, 2009 / Notices
below–cost sales were made in
‘‘substantial quantities’’ within an
extended period of time and at prices
which did not permit the recovery of all
costs within a reasonable period of time
in the normal course of trade. See
sections 773(b)(2)(B) – (D) of the Act.
Therefore, for purposes of these final
results, we found that Ekinciler and
Kaptan made below–cost sales not in
the ordinary course of trade.
Consequently, we disregarded these
sales for Ekinciler and Kaptan and used
the remaining sales as the basis for
determining NV pursuant to section
773(b)(1) of the Act.
Analysis of Comments Received
The issues raised in Kaptan’s case
brief are listed in the Appendix to this
notice and addressed in the Decision
Memo, which is adopted by this notice.
Parties can find a complete discussion
of all issues raised in this review and
the corresponding recommendations in
this public memorandum, which is on
file in the Central Records Unit, room
1117, of the main Department building.
In addition, a complete version of the
Decision Memo can be accessed directly
on the Web at https://ia.ita.doc.gov/frn/.
The paper copy and electronic version
of the Decision Memo are identical in
content.
Pursuant to 19 CFR 351.106(c)(2), we
will instruct CBP to liquidate without
regard to antidumping duties any
entries for which the assessment rate is
de minimis (i.e., less than 0.50 percent).
The Department intends to issue
assessment instructions to CBP 15 days
after the date of publication of these
final results of review.
The Department clarified its
‘‘automatic assessment’’ regulation on
May 6, 2003. See Antidumping and
Countervailing Duty Proceedings:
Assessment of Antidumping Duties, 68
FR 23954 (May 6, 2003). This
clarification will apply to entries of
subject merchandise during the POR
produced by companies included in
these final results of review for which
the reviewed companies did not know
their merchandise was destined for the
United States. In such instances, we will
instruct CBP to liquidate unreviewed
entries at the all–others rate if there is
no rate for the intermediate
company(ies) involved in the
transaction.
pwalker on DSK8KYBLC1PROD with NOTICES
Cash Deposit Requirements
In December 2008, the International
Trade Commission (ITC) determined,
pursuant to section 751(c) of the Act,
that revocation of this order would not
be likely to lead to the continuation or
recurrence of material injury to an
Changes Since the Preliminary Results
industry in the United States within a
Based on our analysis of the
reasonably foreseeable time. See Steel
comments received, we have made
Concrete Reinforcing Bar From Turkey;
certain changes in the margin
Determination, 73 FR 77841 (Dec. 19,
calculation for Kaptan. These changes
2008). See also Steel Concrete
are discussed in detail in the relevant
Reinforcing Bars from Turkey, Inv. No.
sections of the Decision Memo.
701–TA–745 (Second Review), USITC
Pub. 4 (Jan. 2009). As a result of the
Final Results of Review
ITC’s negative determination, the
We determine that the following
Department revoked the order on rebar
weighted–average margin percentages
from Turkey on January 5, 2009,
exist for the period April 1, 2007,
effective as of March 26, 2008 (i.e., the
through March 25, 2008:
fifth anniversary of the date of
publication in the Federal Register of
Manufacturer/Producer/
Margin Percentage the notice of continuation of this
Exporter
antidumping duty order). See
Ekinciler Demir ve Celik
Revocation of Antidumping Duty Order:
Sanayi A.S./Ekinciler
Certain Steel Concrete Reinforcing Bars
Dis Ticaret A.S. .........
0.35 from Turkey, 74 FR 266 (Jan. 5, 2009).
Kaptan Demir Celik
Consequently, the collection of cash
Endustrisi ve Ticaret
deposits of antidumping duties on
A.S. ...........................
0.00
entries of the subject merchandise is no
longer required.
Assessment
The Department shall determine, and
CBP shall assess, antidumping duties on
all appropriate entries, in accordance
with 19 CFR 351.212. Pursuant to 19
CFR 351.212(b)(1), we calculated
importer–specific assessment rates for
each respondent based on the ratio of
the total amount of antidumping duties
calculated for the examined sales to the
total entered value of those sales.
VerDate Nov<24>2008
16:27 Sep 02, 2009
Jkt 217001
Notification to Importers
This notice serves as a final reminder
to importers of their responsibility,
under 19 CFR 351.402(f)(2), to file a
certificate regarding the reimbursement
of antidumping duties prior to
liquidation of the relevant entries
during this review period. Failure to
comply with this requirement could
result in the Secretary’s presumption
PO 00000
Frm 00007
Fmt 4703
Sfmt 4703
that reimbursement of antidumping
duties occurred and the subsequent
assessment of double antidumping
duties.
Notification to Interested Parties
This notice serves as the only
reminder to parties subject to
administrative protective order (APO) of
their responsibility concerning the
disposition of proprietary information
disclosed under APO in accordance
with 19 CFR 351.305(a)(3). Timely
written notification of return/
destruction of APO materials or
conversion to judicial protective order is
hereby requested. Failure to comply
with the regulations and the terms of an
APO is a sanctionable violation.
We are issuing and publishing these
results of review in accordance with
sections 751(a)(1) and 777(i)(1) of the
Act and 19 CFR 351.221(b)(5).
Dated: August 27, 2009.
Ronald K. Lorentzen,
Acting Assistant Secretary for Import
Administration.
Appendix – Issues in Decision
Memorandum
Company–Specific Issues
1. Duty Drawback Adjustment for
Kaptan
2. Cost of Raw Materials Adjustment for
Kaptan
3. Date of Sale for Kaptan
4. Affiliated Party Freight Revenue for
Kaptan
[FR Doc. E9–21321 Filed 9–2–09; 8:45 am]
BILLING CODE 3510–DS–S
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[Docket 36–2009]
Foreign-Trade Zone 170—Clark
County, IN; Application for Subzone;
Schwarz Pharma Manufacturing Ltd.
(Pharmaceuticals Manufacturing),
Seymour, IN
An application has been submitted to
the Foreign-Trade Zones Board (the
Board) by the Ports of Indiana, grantee
of FTZ 170, requesting special-purpose
subzone status for pharmaceutical
manufacturing facility of Schwarz
Pharma Manufacturing Ltd. (Shwarz
Pharma), located in Seymour, Indiana.
The application was submitted pursuant
to the provisions of the Foreign-Trade
Zones Act, as amended (19 U.S.C. 81a–
81u), and the regulations of the Board
(15 CFR part 400). It was formally filed
on August 25, 2009.
The Schwarz Pharma facility (450
employees, 28.8 acres, 1. 8 billion
E:\FR\FM\03SEN1.SGM
03SEN1
pwalker on DSK8KYBLC1PROD with NOTICES
Federal Register / Vol. 74, No. 170 / Thursday, September 3, 2009 / Notices
doses) is located at 1101 C Avenue
West, Seymour, Indiana. The facility is
used to manufacture, test, package and
warehouse pharmaceutical products.
Components and materials sourced from
abroad (representing 75% of the value of
the finished product) include:
alprostidil, edex applicators,
lacosamide, moexipril, kremozin,
vanlafaxim, and esomeprazole
magnesium (duty rate ranges from duty
free to 5.3%). The application also
requests authority to include a broad
range of inputs and finished
pharmaceutical products that Schwarz
Pharma may produce under FTZ
procedures in the future. New major
activity involving these inputs/products
would require review by the FTZ Board.
FTZ procedures could exempt
Schwarz Pharma from customs duty
payments on the foreign components
used in export production. The
company anticipates that less than 5
percent of the plant’s shipments will be
exported. On its domestic sales,
Schwarz Pharma would be able to
choose the duty rates during customs
entry procedures that apply to Edex kits,
Vimpat, Moexipril, Kremozin,
Vanlafaxim and an acid reflux
pharmaceutical (all duty free) for the
foreign inputs noted above. FTZ
designation would further allow
Schwarz Pharma to realize logistical
benefits through the use of weekly
customs entry procedures. Customs
duties also could possibly be deferred or
reduced on foreign status production
equipment. The request indicates that
the savings from FTZ procedures would
help improve the plant’s international
competitiveness.
In accordance with the Board’s
regulations, Diane Finver of the FTZ
Staff is designated examiner to evaluate
and analyze the facts and information
presented in the application and case
record and to report findings and
recommendations to the Board.
Public comment is invited from
interested parties. Submissions (original
and 3 copies) shall be addressed to the
Board’s Executive Secretary at the
address below. The closing period for
their receipt is November 2, 2009.
Rebuttal comments in response to
material submitted during the foregoing
period may be submitted during the
subsequent 15-day period to November
17, 2009.
A copy of the application will be
available for public inspection at the
Office of the Executive Secretary,
Foreign-Trade Zones Board, Room 2111,
U.S. Department of Commerce, 1401
Constitution Avenue, NW., Washington,
DC 20230–0002, and in the ‘‘Reading
Room’’ section of the Board’s Web site,
VerDate Nov<24>2008
16:27 Sep 02, 2009
Jkt 217001
which is accessible via https://
www.trade.gov/ftz.
For further information, contact Diane
Finver at diane_finver@ita.doc.gov or
(202) 482–1367.
Dated: August 26, 2009.
Andrew McGilvray,
Executive Secretary.
[FR Doc. E9–21319 Filed 9–2–09; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
National Oceanic and Atmospheric
Administration
RIN 0648–XN24
Taking and Importing Marine
Mammals; Operations of a Liquified
Natural Gas Port Facility in
Massachusetts Bay
AGENCY: National Marine Fisheries
Service (NMFS), National Oceanic and
Atmospheric Administration (NOAA),
Commerce.
ACTION: Notice of issuance of an
incidental harassment authorization.
SUMMARY: In accordance with
regulations implementing the Marine
Mammal Protection Act (MMPA) as
amended, notification is hereby given
that an Incidental Harassment
Authorization (IHA) to take marine
mammals, by harassment, incidental to
operation of an offshore liquefied
natural gas (LNG) facility in the
Massachusetts Bay, has been issued to
Northeast Gateway Energy BridgeTM
LLC (Northeast Gateway or NEG) for a
period of 1 year.
DATES: This authorization is effective
from August 31, 2009, until August 30,
2010. NMFS has also made the required
findings to support future modification
of the IHA to include take of marine
mammals by Northeast Gateway’s
partner, Algonquin Gas Transmission,
LLC, incidental to operations and
maintenance of the Algonquin Pipeline
Lateral upon completion of consultation
under section 7 of the Endangered
Species Act.
ADDRESSES: A copy of the application,
IHA, and a list of references used in this
document may be obtained by writing to
P. Michael Payne, Chief, Permits,
Conservation and Education Division,
Office of Protected Resources, National
Marine Fisheries Service, 1315 EastWest Highway, Silver Spring, MD
20910–3225. A copy of the application
may be obtained by writing to this
address or by telephoning the contact
listed here and is also available at:
PO 00000
Frm 00008
Fmt 4703
Sfmt 4703
45613
https://www.nmfs.noaa.gov/pr/permits/
incidental.htm#applications.
FOR FURTHER INFORMATION CONTACT:
Shane Guan, Office of Protected
Resources, NMFS, (301) 713–2289, ext
137.
SUPPLEMENTARY INFORMATION:
Background
Sections 101(a)(5)(A) and 101(a)(5)(D)
of the MMPA (16 U.S.C. 1361 et seq.)
direct the Secretary of Commerce
(Secretary) to allow, upon request, the
incidental, but not intentional taking of
marine mammals by U.S. citizens who
engage in a specified activity (other than
commercial fishing) within a specified
geographical region if certain findings
are made and regulations are issued or,
if the taking is limited to harassment, a
notice of a proposed authorization is
provided to the public for review.
Authorization shall be granted if
NMFS finds that the taking will have a
negligible impact on the species or
stock(s), will not have an unmitigable
adverse impact on the availability of the
species or stock(s) for subsistence uses,
and if the permissible methods of taking
and requirements pertaining to the
mitigation, monitoring and reporting of
such taking are set forth. NMFS has
defined ‘‘negligible impact’’ in 50 CFR
216.103 as:
an impact resulting from the specified
activity that cannot be reasonably expected
to, and is not reasonably likely to, adversely
affect the species or stock through effects on
annual rates of recruitment or survival.
Section 101(a)(5)(D) of the MMPA
established an expedited process by
which citizens of the United States can
apply for an authorization to
incidentally take small numbers of
marine mammals by harassment. Except
with respect to certain activities not
pertinent here, the MMPA defines
‘‘harassment’’ as:
any act of pursuit, torment, or annoyance
which (i) has the potential to injure a marine
mammal or marine mammal stock in the wild
[Level A harassment]; or (ii) has the potential
to disturb a marine mammal or marine
mammal stock in the wild by causing
disruption of behavioral patterns, including,
but not limited to, migration, breathing,
nursing, breeding, feeding, or sheltering
[Level B harassment].
Section 101(a)(5)(D) establishes a 45day time limit for NMFS review of an
application followed by a 30-day public
notice and comment period on any
proposed authorizations for the
incidental harassment of marine
mammals. Within 45 days of the close
of the comment period, NMFS must
either issue or deny issuance of the
authorization.
E:\FR\FM\03SEN1.SGM
03SEN1
Agencies
[Federal Register Volume 74, Number 170 (Thursday, September 3, 2009)]
[Notices]
[Pages 45612-45613]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-21319]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[Docket 36-2009]
Foreign-Trade Zone 170--Clark County, IN; Application for
Subzone; Schwarz Pharma Manufacturing Ltd. (Pharmaceuticals
Manufacturing), Seymour, IN
An application has been submitted to the Foreign-Trade Zones Board
(the Board) by the Ports of Indiana, grantee of FTZ 170, requesting
special-purpose subzone status for pharmaceutical manufacturing
facility of Schwarz Pharma Manufacturing Ltd. (Shwarz Pharma), located
in Seymour, Indiana. The application was submitted pursuant to the
provisions of the Foreign-Trade Zones Act, as amended (19 U.S.C. 81a-
81u), and the regulations of the Board (15 CFR part 400). It was
formally filed on August 25, 2009.
The Schwarz Pharma facility (450 employees, 28.8 acres, 1. 8
billion
[[Page 45613]]
doses) is located at 1101 C Avenue West, Seymour, Indiana. The facility
is used to manufacture, test, package and warehouse pharmaceutical
products. Components and materials sourced from abroad (representing
75% of the value of the finished product) include: alprostidil, edex
applicators, lacosamide, moexipril, kremozin, vanlafaxim, and
esomeprazole magnesium (duty rate ranges from duty free to 5.3%). The
application also requests authority to include a broad range of inputs
and finished pharmaceutical products that Schwarz Pharma may produce
under FTZ procedures in the future. New major activity involving these
inputs/products would require review by the FTZ Board.
FTZ procedures could exempt Schwarz Pharma from customs duty
payments on the foreign components used in export production. The
company anticipates that less than 5 percent of the plant's shipments
will be exported. On its domestic sales, Schwarz Pharma would be able
to choose the duty rates during customs entry procedures that apply to
Edex kits, Vimpat, Moexipril, Kremozin, Vanlafaxim and an acid reflux
pharmaceutical (all duty free) for the foreign inputs noted above. FTZ
designation would further allow Schwarz Pharma to realize logistical
benefits through the use of weekly customs entry procedures. Customs
duties also could possibly be deferred or reduced on foreign status
production equipment. The request indicates that the savings from FTZ
procedures would help improve the plant's international
competitiveness.
In accordance with the Board's regulations, Diane Finver of the FTZ
Staff is designated examiner to evaluate and analyze the facts and
information presented in the application and case record and to report
findings and recommendations to the Board.
Public comment is invited from interested parties. Submissions
(original and 3 copies) shall be addressed to the Board's Executive
Secretary at the address below. The closing period for their receipt is
November 2, 2009. Rebuttal comments in response to material submitted
during the foregoing period may be submitted during the subsequent 15-
day period to November 17, 2009.
A copy of the application will be available for public inspection
at the Office of the Executive Secretary, Foreign-Trade Zones Board,
Room 2111, U.S. Department of Commerce, 1401 Constitution Avenue, NW.,
Washington, DC 20230-0002, and in the ``Reading Room'' section of the
Board's Web site, which is accessible via https://www.trade.gov/ftz.
For further information, contact Diane Finver at diane_finver@ita.doc.gov or (202) 482-1367.
Dated: August 26, 2009.
Andrew McGilvray,
Executive Secretary.
[FR Doc. E9-21319 Filed 9-2-09; 8:45 am]
BILLING CODE 3510-DS-P